SEARCH

SEARCH BY CITATION

References

  • 1
    Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774800.
  • 2
    Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:68597.
  • 3
    Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:192935.
  • 4
    Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:4853.
  • 5
    Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 2003;24:30212.
  • 6
    Laukkanen JA, Kurl S, Salonen JT. Cardiorespiratory fitness and physical activity as risk predictors of future atherosclerotic cardiovascular diseases. Curr Atheroscler Rep 2002;4:46876.
  • 7
    Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989;262:2395401.
  • 8
    Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000;132:60511.
  • 9
    Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994;330:154954.
  • 10
    Fleg JL, Pina IL, Balady GJ, Chaitman BR, Fletcher B, Lavie C, et al. Assessment of functional capacity in clinical and research applications: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000;102:15917.
  • 11
    Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002;13:2517.
  • 12
    Moran LJ, Brinkworth G, Noakes M, Norman RJ. Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online 2006;12:56978.
  • 13
    Bertoli A, Daniele N, Ceccobelli M, Ficara A, Girasoli C, Lorenzo A. Lipid profile, BMI, body fat distribution, and aerobic fitness in men with metabolic syndrome. Acta Diabetol 2003;40:s1303.
  • 14
    Molnar D, Porszasz J. The effect of fasting hyperinsulinaemia on physical fitness in obese children. Eur J Pediatr 1990;149:5703.
  • 15
    Ugur-Altun B, Altun A, Tatli E, Arikan E, Tugrul A. Relationship between insulin resistance assessed by HOMA-IR and exercise test variables in asymptomatic middle-aged patients with type 2 diabetes. J Endocrinol Invest 2004;27:45561.
  • 16
    Nyholm B, Mengel A, Nielsen S, Skjaerbaek C, Moller N, Alberti KG, et al. Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism. Diabetologia 1996;39:81322.
  • 17
    Schneider SH, Khachadurian AK, Amorosa LF, Gavras H, Fineberg SE, Ruderman NB. Abnormal glucoregulation during exercise in type II (non-insulin-dependent) diabetes. Metabolism 1987;36:11616.
  • 18
    Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995;27:87581.
  • 19
    Meyer C, McGrath BP, Teede HJ. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 2005;90:57116.
  • 20
    Segal KR, Dunaif A. Resting metabolic rate and postprandial thermogenesis in polycystic ovarian syndrome. Int J Obes 1990;14:55967.
  • 21
    Cosar E, Köken G, Sahin FK, Akgün L, Üçok K, Genç A, et al. Resting metabolic rate and exercise capacity in women with polycystic ovary syndrome. Int J Gynaecol Obstet 2008;101:3134.
  • 22
    Orio F Jr, Giallauria F, Palomba S, Cascella T, Manguso F, Vuolo L, et al. Cardiopulmonary impairment in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:296771.
  • 23
    Jurca R, Lamonte MJ, Church TS, Earnest CP, Fitzgerald SJ, Barlow CE, et al. Associations of muscle strength and fitness with metabolic syndrome in men. Med Sci Sports Exerc 2004;36:13017.
  • 24
    Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:7688.
  • 25
    Wilson JR. Evaluation of skeletal muscle fatigue in patients with heart failure. J Mol Cell Cardiol 1996;28:228792.
  • 26
    Visser M, Newman AB, Nevitt MC, Kritchevsky SB, Stamm EB, Goodpaster BH, et al. Reexamining the sarcopenia hypothesis. Muscle mass versus muscle strength. Health, Aging, and Body Composition Study Research Group. Ann N Y Acad Sci 2000;904:45661.
  • 27
    Lazarus R, Sparrow D, Weiss ST. Handgrip strength and insulin levels: cross-sectional and prospective associations in the normative aging study. Metabolism 1997;46:12669.
  • 28
    Abbatecola AM, Ferrucci L, Ceda G, Russo CR, Lauretani F, Bandinelli S, et al. Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 2005;60:127882.
  • 29
    Miyatake N, Wada J, Saito T, Nishikawa H, Matsumoto S, Miyachi M, et al. Comparison of muscle strength between Japanese men with and without metabolic syndrome. Acta Med Okayama 2007;61:99102.
  • 30
    Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:294451.
  • 31
    The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:4147.
  • 32
    Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:93642.
  • 33
    Philippaerts RM, Westerterp KR, Lefevre J. Doubly labelled water validation of three physical activity questionnaires. Int J Sports Med 1999;20:2849.
  • 34
    American College of Sports Medicine. Guidelines for Exercise Testing and Prescription, 6th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2000.
  • 35
    Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2:9298.
  • 36
    Howley ET, Bassett DR Jr, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc 1995;27:1292301.
  • 37
    Wasserman K, Hansen J, Sue D, Whipp B. Principles of Exercise Testing and Interpretation, 2nd edn. Philadelphia, PA: Williams & Wilkins, 1994.
  • 38
    Gross M, Hoffman G, Phillips C, Wray J. Intramachine and intermachine reliability of the Biodex and Cybex II for knee flexion and extension peak torque and angular work. J Orthop Sports Phys Ther 1991;13:32935.
  • 39
    Pincivero DM, Gear WS, Sterner RL. Assessment of the reliability of high-intensity quadriceps femoris muscle fatigue. Med Sci Sports Exerc 2001;33:3348.
  • 40
    Kim HJ, Kramer JF. Effectiveness of visual feedback during isokinetic exercise. J Orthop Sports Phys Ther 1997;26:31823.
  • 41
    Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr 2006;84:7787.
  • 42
    Noakes M, Keogh JB, Foster PR, Clifton PM. Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr 2005;81:1298306.
  • 43
    Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:148795.
  • 44
    Ekkekakis P, Lind E. Exercise does not feel the same when you are overweight: the impact of self-selected and imposed intensity on affect and exertion. Int J Obes (Lond) 2006;30:65260.
  • 45
    Fornitano LD, Godoy MF. Exercise testing in individuals with morbid obesity. Obes Surg: DOI 10.1007/s11695-008-9692-7 (E-pub ahead of print).
  • 46
    Ugur-Altun B, Altun A, Tatli E, Tugrul A. Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients. Diabetes Res Clin Pract 2005;67:1306.
  • 47
    Regensteiner JG. Type 2 diabetes mellitus and cardiovascular exercise performance. Rev Endocr Metab Disord 2004;5:26976.
  • 48
    Van De Borne P, Hausberg M, Hoffman RP, Mark AL, Anderson EA. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 1999;276:R17883.
  • 49
    Valensi P, Nguyen TN, Idriss S, Cazes P, Karam G, Paries J, et al. Influence of parasympathetic dysfunction and hyperinsulinemia on the hemodynamic response to an isometric exercise in non-insulin-dependent diabetic patients. Metabolism 1998;47:9349.
  • 50
    Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002;77:1095105.
  • 51
    DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:145460.
  • 52
    Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006;154:1415.
  • 53
    Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 2007;67:73542.
  • 54
    Carmina E, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 2006;86 (Suppl 1):S78.
  • 55
    Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BGA. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 2008;23:23528.
  • 56
    Alberti KG, Zimmet PZ, Shaw JE. Metabolic syndrome––a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:46980.
  • 57
    Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004;82:6615.
  • 58
    Robertson RJ. Central signals of perceived exertion during dynamic exercise. Med Sci Sports Exerc 1982;14:3906.
  • 59
    Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:137984.
  • 60
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:337380.
  • 61
    Kondo N, Nomura M, Nakaya Y, Ito S, Ohguro T. Association of inflammatory marker and highly sensitive C-reactive protein with aerobic exercise capacity, maximum oxygen uptake and insulin resistance in healthy middle-aged volunteers. Circ J 2005;69:4527.
  • 62
    LaMonte MJ, Durstine JL, Yanowitz FG, Lim T, DuBose KD, Davis P, et al. Cardiorespiratory fitness and C-reactive protein among a tri-ethnic sample of women. Circulation 2002;106:4036.
  • 63
    Church TS, Barlow CE, Earnest CP, Kampert JB, Priest EL, Blair SN. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vasc Biol 2002;22:186976.
  • 64
    Giallauria F, Palomba S, De Sio I, Maresca L, Vuolo L, Savastano S, et al. Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2009;70:394400.
  • 65
    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:4258.
  • 66
    Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:83643.
  • 67
    Giallauria F, Palomba S, Maresca L, Vuolo L, Tafuri D, Lombardi G, et al. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome. Clin Endocrinol 2008;69:7928.
  • 68
    Karelis AD, Tousignant B, Nantel J, Proteau-Labelle M, Malita FM, St-Pierre DH, et al. Association of insulin sensitivity and muscle strength in overweight and obese sedentary postmenopausal women. Appl Physiol Nutr Metab 2007;32:297301.
  • 69
    Stenholm S, Rantanen T, Heliovaara M, Koskinen S. The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc 2008;56:4629.
  • 70
    Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWHJ, Lenchik L, et al. Sarcopenia, obesity, and inflammation––results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 2005;82:42834.
  • 71
    Bross R, Casaburi R, Storer TW, Bhasin S. Androgen effects on body composition and muscle function: implications for the use of androgens as anabolic agents in sarcopenic states. Baillieres Clin Endocrinol Metab 1998;12:36578.
  • 72
    Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335:17.
  • 73
    Rolland Y, Lauwers-Cances V, Cristini C, Grandjean H, Banks WA, Morley JE, et al. Disability in obese elderly women: lower limb strength and recreational physical activity. Obes Res Clin Pract 2007;1:3951.
  • 74
    Wright CE, Zborowski JV, Talbott EO, McHugh-Pemu K, Youk A. Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome. Int J Obes Relat Metab Disord 2004;28:102632.